BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

539428

TEJNAKSH

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Tejnaksh Healthcare Limited Share Price Update

As of the latest trading session, Tejnaksh Healthcare Limited share price is currently at ₹ 16.81, which is down by ₹ -0.14 from its previous closing. Today, the stock has fluctuated between ₹ 16.55 and ₹ 17.25. Over the past year, Tejnaksh Healthcare Limited has achieved a return of -28.29 %. In the last month alone, the return has been -6.91 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Tejnaksh Healthcare Limited fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    34.20

  • P/E Ratio (TTM)

    14.49

  • Beta

    0.40

  • Book Value / share

    12.50

  • Return on equity

    10.87%

  • EPS (TTM)

    1.17

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.34

info icon alternate text

Tejnaksh Healthcare Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 1.78
Operating Expense 1.41
Net Profit 0.34
Net Profit Margin (%) 19.10
Earnings Per Share (EPS) 0.17
EBITDA 0.82
Effective Tax Rate (%) 24.44
Particulars MAR 2025 (Values in Cr)
Revenue 2.40
Operating Expense 1.43
Net Profit 0.75
Net Profit Margin (%) 31.25
Earnings Per Share (EPS) 0.37
EBITDA 1.23
Effective Tax Rate (%) 26.92
Particulars DEC 2024 (Values in Cr)
Revenue 2.24
Operating Expense 1.16
Net Profit 0.72
Net Profit Margin (%) 32.14
Earnings Per Share (EPS) 0.36
EBITDA 1.49
Effective Tax Rate (%) 40.49
Particulars SEP 2024 (Values in Cr)
Revenue 1.98
Operating Expense 1.43
Net Profit 0.56
Net Profit Margin (%) 28.28
Earnings Per Share (EPS) 0.31
EBITDA 1.01
Effective Tax Rate (%) 11.11
Particulars JUN 2024 (Values in Cr)
Revenue 2.18
Operating Expense 1.47
Net Profit 0.58
Net Profit Margin (%) 26.60
Earnings Per Share (EPS) 0.29
EBITDA 1.10
Effective Tax Rate (%) 25.64
Particulars MAR 2025 (Values in Cr)
Revenue 8.80
Operating Expense 5.49
Net Profit 2.62
Net Profit Margin (%) 29.77
Earnings Per Share (EPS) 1.29
EBITDA 4.83
Effective Tax Rate (%) 28.41
Particulars MAR 2024 (Values in Cr)
Revenue 8.22
Operating Expense 6.07
Net Profit 1.81
Net Profit Margin (%) 22.01
Earnings Per Share (EPS) 0.89
EBITDA 3.92
Effective Tax Rate (%) 25.51
Particulars MAR 2023 (Values in Cr)
Revenue 7.34
Operating Expense 5.60
Net Profit 1.38
Net Profit Margin (%) 18.80
Earnings Per Share (EPS) 0.68
EBITDA 3.36
Effective Tax Rate (%) 29.59
Particulars MAR 2022 (Values in Cr)
Revenue 8.12
Operating Expense 4.88
Net Profit 2.52
Net Profit Margin (%) 31.03
Earnings Per Share (EPS) 2.48
EBITDA 4.43
Effective Tax Rate (%) 25.22
Particulars MAR 2021 (Values in Cr)
Revenue 8.56
Operating Expense 6.13
Net Profit 2.00
Net Profit Margin (%) 23.36
Earnings Per Share (EPS) 1.97
EBITDA 3.73
Effective Tax Rate (%) 22.77
Particulars MAR 2025 (Values in Cr)
Book Value / Share 12.76
ROE % 9.01
ROCE % 12.77
Total Debt to Total Equity 0.12
EBITDA Margin 34.88
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.60
ROE % 7.76
ROCE % 10.64
Total Debt to Total Equity 0.25
EBITDA Margin 32.35
Particulars MAR 2023 (Values in Cr)
Book Value / Share 21.43
ROE % 8.56
ROCE % 11.24
Total Debt to Total Equity 0.32
EBITDA Margin 34.19
Particulars MAR 2022 (Values in Cr)
Book Value / Share 19.75
ROE % 15.03
ROCE % 17.08
Total Debt to Total Equity 0.32
EBITDA Margin 38.72
Particulars MAR 2021 (Values in Cr)
Book Value / Share 17.05
ROE % 12.71
ROCE % 14.10
Total Debt to Total Equity 0.37
EBITDA Margin 32.19
Particulars MAR 2025 (Values in Cr)
Book Value / Share 12.51
ROE % 10.87
ROCE % 14.64
Total Debt to Total Equity 0.12
EBITDA Margin 55.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.21
ROE % 8.28
ROCE % 11.12
Total Debt to Total Equity 0.26
EBITDA Margin 47.81
Particulars MAR 2023 (Values in Cr)
Book Value / Share 20.62
ROE % 6.81
ROCE % 9.41
Total Debt to Total Equity 0.33
EBITDA Margin 45.91
Particulars MAR 2022 (Values in Cr)
Book Value / Share 19.25
ROE % 13.77
ROCE % 15.63
Total Debt to Total Equity 0.33
EBITDA Margin 54.68
Particulars MAR 2021 (Values in Cr)
Book Value / Share 16.76
ROE % 12.48
ROCE % 13.82
Total Debt to Total Equity 0.38
EBITDA Margin 43.69
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.79
Total Assets 30.30
Total Liabilities 30.30
Total Equity 26.45
Share Outstanding 20314000
Price to Book Ratio 1.68
Return on Assets (%) 7.68
Return on Capital (%) 8.59
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.25
Total Assets 31.35
Total Liabilities 31.35
Total Equity 24.20
Share Outstanding 20314000
Price to Book Ratio 2.07
Return on Assets (%) 5.66
Return on Capital (%) 6.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.13
Total Assets 31.22
Total Liabilities 31.22
Total Equity 22.41
Share Outstanding 10156800
Price to Book Ratio 3.34
Return on Assets (%) 5.38
Return on Capital (%) 5.95
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.00
Total Assets 29.60
Total Liabilities 29.60
Total Equity 20.59
Share Outstanding 10156800
Price to Book Ratio 8.75
Return on Assets (%) 9.19
Return on Capital (%) 10.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.23
Total Assets 24.57
Total Liabilities 24.57
Total Equity 17.76
Share Outstanding 10156800
Price to Book Ratio 4.34
Return on Assets (%) 8.35
Return on Capital (%) 9.35
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.64
Total Assets 29.00
Total Liabilities 29.00
Total Equity 25.40
Share Outstanding 20314000
Price to Book Ratio 1.68
Return on Assets (%) 9.03
Return on Capital (%) 10.07
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.94
Total Assets 30.11
Total Liabilities 30.11
Total Equity 22.77
Share Outstanding 20314000
Price to Book Ratio 2.07
Return on Assets (%) 6.01
Return on Capital (%) 6.74
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.47
Total Assets 29.80
Total Liabilities 29.80
Total Equity 20.94
Share Outstanding 10156800
Price to Book Ratio 3.34
Return on Assets (%) 4.62
Return on Capital (%) 5.13
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.43
Total Assets 28.67
Total Liabilities 28.67
Total Equity 19.55
Share Outstanding 10156800
Price to Book Ratio 8.75
Return on Assets (%) 8.78
Return on Capital (%) 9.73
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.56
Total Assets 23.87
Total Liabilities 23.87
Total Equity 17.02
Share Outstanding 10156800
Price to Book Ratio 4.34
Return on Assets (%) 8.39
Return on Capital (%) 9.43
Particulars MAR 2025 (Values in Cr)
Net Income 3.19
Cash from Operations 0.85
Cash from Investing 3.52
Cash from Financing -3.86
Net change in Cash 0.03
Free Cash Flow 1.10
Particulars MAR 2024 (Values in Cr)
Net Income 2.37
Cash from Operations 4.34
Cash from Investing -1.01
Cash from Financing -2.26
Net change in Cash 0.72
Free Cash Flow 5.04
Particulars MAR 2023 (Values in Cr)
Net Income 2.51
Cash from Operations 1.70
Cash from Investing -1.40
Cash from Financing -1.19
Net change in Cash -0.47
Free Cash Flow 2.52
Particulars MAR 2022 (Values in Cr)
Net Income 3.76
Cash from Operations 8.96
Cash from Investing -10.58
Cash from Financing 1.61
Net change in Cash 0.23
Free Cash Flow 18.04
Particulars MAR 2021 (Values in Cr)
Net Income 2.66
Cash from Operations 0.47
Cash from Investing 1.55
Cash from Financing -2.80
Net change in Cash -0.06
Free Cash Flow 0.91
Particulars MAR 2025 (Values in Cr)
Net Income 3.66
Cash from Operations 0.97
Cash from Investing 3.57
Cash from Financing -3.86
Net change in Cash 0.19
Free Cash Flow 1.16
Particulars MAR 2024 (Values in Cr)
Net Income 2.43
Cash from Operations 4.47
Cash from Investing -1.07
Cash from Financing -2.31
Net change in Cash 0.75
Free Cash Flow 4.90
Particulars MAR 2023 (Values in Cr)
Net Income 1.96
Cash from Operations 1.51
Cash from Investing -0.98
Cash from Financing -1.17
Net change in Cash -0.25
Free Cash Flow 2.20
Particulars MAR 2022 (Values in Cr)
Net Income 3.37
Cash from Operations 8.88
Cash from Investing -10.39
Cash from Financing 1.61
Net change in Cash 0.34
Free Cash Flow 17.74
Particulars MAR 2021 (Values in Cr)
Net Income 2.59
Cash from Operations 0.34
Cash from Investing 1.55
Cash from Financing -2.86
Net change in Cash -0.46
Free Cash Flow 0.78
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7844.90 71.69 13.74 112797.63 6002.15 / 8099.00
FORTIS MALAR HOSPITALS LIMITED 67.58 27.47 4.19 126.66 51.27 / 98.70
SHREE PACETRONIX LTD. 269.70 93.00 7.04 97.08 61.11 / 269.70
TRANSGENE BIOTEK LTD. 4.16 0.00 3.14 31.52 3.22 / 8.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7844.90 83.47 12.91 112797.63 6002.15 / 8099.00
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 53.42 0.00 -21.15 39.90 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 6647.45 32.99 6.69 7272.31 4777.15 / 6725.00

Tejnaksh Healthcare Limited shareholding pattern

Holding

Others
26.16%
Promoter Holdings
73.83%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Ashish Vishwas Rawandale 7749202.0 (38.15%) Shareholding of Promoter and Promoter Group
Preeti Ashish Rawandale 7217932.0 (35.53%) Shareholding of Promoter and Promoter Group
Sheetal Utkarsh Rawandale 294400.0 (1.45%) Public Shareholding
Sonal Lohia 274989.0 (1.35%) Public Shareholding
Pramila Vishwasrao Patil 31018.0 (0.15%) Shareholding of Promoter and Promoter Group
Utkarsh Vishwas Rawandale 18.0 (0.0%) Shareholding of Promoter and Promoter Group

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

Tejnaksh Healthcare Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
16.85 -0.58 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 17.30
  • 26 Days 17.90
  • 10 Days 17.50
  • 50 Days 18.30
  • 12 Days 17.60
  • 100 Days 19.20
  • 20 Days 17.80
  • 200 Days 20.70
17.13 PIVOT

First Support

16.76

First Resistance

17.31

Second Support

16.58

Second Resistance

17.68

Third Support

16.21

Third Resistance

17.86

RSI

34.94

ADX

41.85

MACD

-0.34

Williams % R

-72.01

Commodity Channel Index (CCI)

-113.25

Date

2025-10-27

Week

4214.00

Same Day

1483.00

Month

4638.00

1 Year

0.40

3 Year

0.66

Over 1 Month

-6.91%

down

Over 1 Year

-28.29%

down

Over 3 Months

-11.11%

down

Over 3 Years

-34.03%

down

Over 6 Months

-23.26%

down

Over 5 Years

2.57%

down

Tejnaksh Healthcare Limited Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
28 Apr 2018 26 Apr 2018 36:10
09 Mar 2017 08 Mar 2017 1:1
Ex-Date Old FV NEW FV Record Date
19 Jul 2023 10.0 5.0 19 Jul 2023

Tejnaksh Healthcare Limited Share Price

Tejnaksh Healthcare Limited was incorporated in Mumbai as 'Tejnaksh Healthcare Private Limited' on 18 February, 2008 as a Private Limited Company. Company was converted to a Public Limited Company and the name was changed to 'Tejnaksh Healthcare Limited' vide fresh Certificate of Incorporation dated 10 March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra.

The Company run an Institute of Urology, an ISO certified the international level Urology hospital, located in Dhule, Maharashtra. It provides a comprehensive range of services from consultations and investigations to treatment for Urology. The main objective of Hospital namely Institute of Urology is to provide the people of Khandesh region of Maharashtra, the services of a super specialty hospital at an affordable rate.

Initiated with a vision to strengthen healthcare in rural India, the Company started its journey from Institute of Urology, a state of the art flagship, kidney care center in Dhule in the year 2003. A recognized teaching institute by the Ministry of Health and Family welfare, the Company provides quality healthcare services at 13 urology clinics, 4 urology hospitals and 2 dental super specialty clinics. The Company's achievements were the multiple records that motivates the customers to improve treatment for Urology.

In 2005, the Company started the 1st Urodynamics Lab of North Maharashtra. In 2006 , it established First Urology CME for the amily physicians. In 2007, it set up 1st Laser Unit and 1st Flexible Ureteroscope of North Maharashtra. In 2009, the Company was into Urology and healthcare training, recognized by The National Board of Examination.

In October 2015, the Company made a public issue of 3,04,000 Equity Shares of Rs 10/- each by raising funds aggregating to Rs. 2.44 Crores.

In 2015, the Company hosted the first PCNL workshop and became a public limited company. During the same year, the Company first dental speciality clinic took the initiative to set up The International Health Tourism. In 2016, the Company set up the first indigenous PCNL simulation lab in the country and were made commercially available during the year. The Company started Urology and Dental centers at Malegaon (MS), Sendhwa (MP) and a multi-speciality center in Navi Mumbai in 2016.

Parent organization Indian Private
NSE symbol [-]
Founded 2008
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Tejnaksh Healthcare Ltd?

Answer Field

Tejnaksh Healthcare Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 16.85 as on Oct 28 2025 03:23 PM.

What is the Market Cap of Tejnaksh Healthcare Ltd Share?

Answer Field

The market cap of Tejnaksh Healthcare Ltd for NSE ₹ 0.00 & for BSE ₹ 34.20 as on Oct 28 2025 03:23 PM.

What is the 52 Week High and Low of Tejnaksh Healthcare Ltd?

Answer Field

The 52 Week High and Low of Tejnaksh Healthcare Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 29.50 and ₹ 16.20.

What is 1 year return for Tejnaksh Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been -28.29%.

What is the P/E Ratio of Tejnaksh Healthcare Ltd Share?

Answer Field

As on Oct 28 2025 03:23 PM the price-to-earnings (PE) ratio for Tejnaksh Healthcare Ltd share is 14.49.

What is the PB ratio of Tejnaksh Healthcare Ltd Share?

Answer Field

As on Oct 28 2025 03:23 PM, the price-to-book (PB) ratio for Tejnaksh Healthcare Ltd share is 12.50.

How to Buy Tejnaksh Healthcare Ltd Share?

Answer Field

You can trade in Tejnaksh Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Tejnaksh Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Tejnaksh Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Tejnaksh Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59